Fresenius Medical Care recently accelerated the second tranche of its €1.00 billion share buyback program, committing about €415 million to repurchases between January and May 2026 as part of its FME ...

Qure N.V. (NASDAQ:QURE) shares are popping on Friday after the company said the FDA will review the data package for AMT‑130, ...

EPS growth, with buybacks, dividends and deleveraging driving 10%+ yield. Read the latest analysis on the stock here.

Aritzia Inc. reported its first-ever billion-dollar quarter for the third quarter of Fiscal 2026, with sales reaching CA$1.04 ...

Recapture is a seller's right to reclaim previously sold assets within a specified timeframe. Explore how it functions in ...

Learn about evergreen options, a stock plan granting shares yearly, including benefits, limitations, and how they may affect ...